Randomised double-blind controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline (PTX) in patients suffering long-term adverse effects of radiotherapy for pelvic cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Pentoxifylline (Primary) ; Tocotrienols (Primary)
- Indications Gastrointestinal disorders; Radiation-induced abnormalities
- Focus Therapeutic Use
- Acronyms PPALM
- 06 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2016 Planned End Date changed from 5 Jan 2017 to 1 Jul 2017 as reported by United Kingdom Clinical Research Network.
- 03 Dec 2015 Accrual to date is 25% as reported by United Kingdom Clinical Research Network record.